胸腔镜肺叶切除术治疗肺良性疾病

目的探讨胸腔镜肺叶切除术在肺良性疾病中的应用价值。方法2002年7月-2007年9月,对35例肺良性疾病行胸腔镜肺叶切除手术。12例施行胸腔镜辅助小切口肺叶切除术,23例施行全胸腔镜肺叶切除术。结果1例因出血中转开胸。全组无围手术期死亡,围手术期并发症3例（8.6%）：术后肺持续漏气2例,肺部感染1例。平均胸管置管时间3.6 d（2-7 d）,术后住院平均7.7 d（2-14 d）。术后病理：支气管扩张15例,炎性假瘤6例,结核5例,真菌感染5例,肺隔离症2例,肺囊肿2例。35例随访5-80个月,平均36.7月,均恢复良好。35例随访5-80个月,平均36.7月,均恢复良好。结论胸腔镜肺叶切除术治疗肺良性疾病在技术上是安全可行的,对于具有手术指征须行肺叶切除的肺良性疾病患者,胸腔镜手术是一种值得推荐的手术方式。

Video-assisted Thoracoscopic Lobectomy for Pulmonary Benign Diseases

Objective To evaluate the safety and efficacy of thoracoscopic lobectomy for pulmonary benign diseases. Methods Between July 2002 and September 2007, 35 cases with pulmonary benign diseases underwent thoracoseopic lobectomy in our hospital. Of the patients,video-assisted thoracoseopic lobectomy was performed on 12 cases,and totally endoscopic lobeetomy was carried out in 23. Results The operation was completed in all of the cases except in one who was cqnverted to open surgery because of massive hemorrhage. In this series, no peri-operational death occurred, however, complications occurred in 3 cases （morbidity rate： 8.6% ） , including 2 cases of persistent air leak and 1 case of pneumonia. The mean duration of chest tube drainage was 3.6 days （2 to 7 days）, and average hospital stay after operation was 7.7 days （2 to 14 days）. Postoperative pathological diagnosis included bronehiectasis in 15 patients, pulmonary inflammatory pseudo-tumor in 6, tuberculosis in 5, fungal infection in 5, pulmonary sequestration in 2, and bronchogenic cyst in 2. Conclusions Thoracoscopic lobectomy is safe and effective for pulmonary benign disease.